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INHIBITORS OF LIPEMIA CLEARING IN TISSUESt
B. KLEIN, M.D., W. F. LEVER, M.D. AND L. L. FEKETE, M.D.
(With the assistance of D. M. Duckett, Jr., B.S.)
The presence in serum of inhibitors of lipemia
clearing activity has been previously reported
(1, 2, 3, 4). Preliminary studies on inhibition of
lipemia clearing activity present in the tissues of
humans and rabbits are reported here.
METHODS AND MATERIALS
A number of tissues (spleen, kidney, liver, heart,
lung, skin, testis, aorta, skeletal muscle, brain,
thymus, thyroid and adrenals), obtained from
humans at autopsy and from exsanguinated rab-
bits, were homogenized in one volume of physi-
ological saline and the mixtures were centrifuged
at 2500 g for 30 minutes at 4°C. The supernatants
were passed through Seitz filters and then centri-
fuged at 32,000 g for 30 minutes at 4°C. The inhibi-
tory activity of the supernatants and of their
sediments, resuspended in an equal volume of
saline, was determined by optical density measure-
ments. For that purpose 0.6 cc. of post-heparin
serum, prepared as previously described (3), was
mixed with 0.6 cc. of tissue extract. To the mixture
0.1 cc. of a solution of 100 units of thrombint
per cc. of saline was added. After incubation for 10
minutes at 37°C. the fibrin clots, from which the
fluid had been expressed, were removed. To these
preparations 0.3 cc. of a standard fat emulsion,t
prepared as previously described (3), was added
and optical density determinations were carried
out according to the method of Grossman (5).
The glycerol evolution in the mixture described
above was determined prior to and one hour after
incubation at 37°C. by Korn's modification (6)
of the method of Lambert and Neish (7). The
eleetrophoretic mobilities of the alpha and beta
lipoproteins in these mixtures were determined
as described by Herbst, Lever and Hurley (8).
RE5IIILTS
The supernatants obtained by high speed centri-
fugation of human and rabbit tissues inhibited
heparin induced lipemia clearing, although the
degree of inhibitory activity varied in different
organs. Extracts of kidney, spleen and liver were
strongly inhibitory, those of heart, lung, skeletal
muscle, testis, adrenals and thyroid exercised
moderate inhibition, while skin, aorta, brain and
adipose tissue were slightly inhibitory. (Table 1)
The variations in the degree of inhibitory
activity were less than 20 per cent in the human
tissues which were strongly inhibitory (kidney,
spleen and liver). In the other human tissues,
however, the variation exceeded 20 per cent and
ranged up to 100 per cent for cardiac tissue.
The strongly inhibitory extracts prevented the
formation of gyeerol and the increased rate of
electrophoretic migration of the alpha and beta
lipoproteins.
The inhibitory activities are destroyed by heat-
TABLE I
The effects of extracts prepared from human tissues
on the heparin induced lipcmia clearing
activity of human serum
Spleen
Kidney
Liver
Lung
Psoas muscle.
Heart
Aorta
Skin
Testis
Adrenals
Thyroid
Brain
Adipose tissue.
Control (saline)..
Optical Density at Varying
Time, of Incubation
Source of
Extract III Minute,
'From the Research Laboratories of the De-
partment of Dermatology, Harvard Medical
School, at the Massachusetts General Hospital,
Boston, Mass.
This investigation was supported by researchgrants from the National Institute of Arthritis
and Metabolic Diseases of the National Institutes
of Health, United States Public Health Service,
A-414 (CS and C6), The Upjohn Company, and
from the Milton Fund, Harvard University.
Received for publication November 9, 1957.
Topical thrombin, Parke, Davis and Com-
pany, Detroit, Michigan.
t The standard fat emulsion contained 15%
coconut oil, 0.5% Pluronic (a non-ionic detergent)
and 1% polyglycerol oleate. It was generously
supplied by Dr. B. A. Hawk of The Upjohn Com-
pany, Kalamazoo, Michigan.
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ing at 100°C. for 10 minutes and are not affected
by dialysis against running water at 15°C. for
24 hours.
DISCUSSION
The role of tissue inhibitors, as described in this
paper, is not known. They may act as regulators
of either the tissue clearing factor (6, 9) or of
a circulating clearing factor.
The lowest degree of inhibition was found at
sites which are rich in fat (adipose tissue, brain),
or fibrous tissue (skin, aorta). It is of interest that
xanthomatous deposits show a predilection for the
latter two tissues.
SUMMARY
Extracts of human and rabbit tissues were found
to inhibit heparin induced lipemia clearing acti-
vity according to spectrometric determinations,
glycerol evolution and the electrophoretic mo-
bilities of the lipoproteins.
Skin, adipose tissue, brain and aorta were
slightly inhibitory; heart, lung, muscle, testis,
thyroid and adrenals were moderately inhibitory
and spleen, kidney and liver were strongly inhibi-
tory.
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